Time in therapeutic range inwarfarin-treated patients is very good good enough?

Nursing and Health Professions

• Alka-Seltzer 60%
• Anticoagulant Agent 20%
• Anticoagulation 20%
• Antivitamin K 30%
• Atrial Fibrillation 50%
• Bleeding 20%
• Brain Hemorrhage 40%
• CHA2DS2-VASc Score 10%
• Cohort Analysis 10%
• Combination Therapy 100%
• Complication 40%
• Control 30%
• Death 10%
• Diabetes Mellitus 10%
• Drug Therapy 10%
• Female 10%
• Hazard Ratio 10%
• Health Care System 10%
• Heart Failure 10%
• Hospital 10%
• Hypertension 10%
• Incidence 20%
• Inpatient 30%
• International Normalized Ratio 60%
• Kidney Failure 10%
• Patient 60%
• Prevention 10%
• Primary Health Care 10%
• Prophylaxis 10%
• Thromboembolism 20%
• Time 20%
• Warfarin 60%

INIS

• anticoagulants 20%
• aspirin 60%
• comparative evaluations 10%
• control 30%
• data 20%
• death 10%
• design 10%
• diabetes mellitus 10%
• failures 20%
• females 10%
• hazards 10%
• hypertension 10%
• kidneys 20%
• levels 10%
• patients 90%
• probability 10%
• prophylaxis 10%
• range 40%
• risks 40%
• safety 20%
• sex 10%
• sweden 10%
• therapy 60%
• vascular diseases 10%
• vitamin k 30%

Pharmacology, Toxicology and Pharmaceutical Science

• Acetylsalicylic Acid 60%
• Anticoagulant Agent 30%
• Antivitamin K 30%
• Atrial Fibrillation 50%
• Bleeding 20%
• Brain Hemorrhage 40%
• Complication 40%
• Death 10%
• Diabetes Mellitus 10%
• Heart Failure 10%
• Hypertension 10%
• Incidence 20%
• Kidney Failure 10%
• Thromboembolism 20%
• Vascular Disease 10%
• Warfarin 60%